Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
about
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomasEbp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.New therapeutic targets in soft tissue sarcoma.The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.Male sterility and enhanced radiation sensitivity in TLS(-/-) mice.Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analysesInvolvement of the PI3K/Akt pathway in myxoid/round cell liposarcomaFrequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms.Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.Induction of a secreted protein by the myxoid liposarcoma oncogeneMolecular approaches to sarcoma therapy.A multifunctional protein, EWS, is essential for early brown fat lineage determination.DDIT3 Expression in Liposarcoma Development.Liposarcoma: molecular genetics and therapeutics.Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.
P2860
Q28076210-7AD4C420-15C1-4870-89A0-42CDBFECFB1DQ30493247-B905C064-A107-4D57-A3B3-50A715AA36F9Q34267924-ED7DD107-3CB6-48E5-962B-71D0DD23181AQ34566943-0C9D9B5E-B163-4461-8083-34B4D458E88BQ34662602-C543C3D2-8E13-4E1D-AB08-EC1DA3C18F25Q35350362-0E2A7DBD-A87F-4239-80BE-3D10B794BB0FQ35700114-371FB3D5-3723-4ACD-B2DE-78753F63A3F5Q35788035-C15C6EC3-4558-460C-B415-607FCC7BEAD6Q35869259-4E7FFB60-E1D2-429A-A17E-9BBEEA65E0F4Q36336254-90306319-A6D8-49FB-B7A4-09E91C7D8303Q37180948-46D63E49-F698-448D-AC6A-0743C4F8208DQ37280590-01C50A6F-4923-42B9-AF8A-A8EC86C27E85Q37699897-52E30ABD-EAD0-4C3E-BC4C-49C89CD7702EQ37831160-2EB6CE8A-E747-46AE-9288-D4D5604A98F2Q39652400-ADA50FD6-F3E4-4AAA-A36D-1519637BDB90
P2860
Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Oncogenic transformation and i ...... CHOP type II chimeric protein.
@ast
Oncogenic transformation and i ...... CHOP type II chimeric protein.
@en
type
label
Oncogenic transformation and i ...... CHOP type II chimeric protein.
@ast
Oncogenic transformation and i ...... CHOP type II chimeric protein.
@en
prefLabel
Oncogenic transformation and i ...... CHOP type II chimeric protein.
@ast
Oncogenic transformation and i ...... CHOP type II chimeric protein.
@en
P2093
P2860
P1476
Oncogenic transformation and i ...... CHOP type II chimeric protein.
@en
P2093
P2860
P304
P407
P577
1997-09-01T00:00:00Z